SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: BDR who wrote (1253)12/23/1997 12:45:00 AM
From: Bruce Rosen  Read Replies (2) | Respond to of 7041
 
Dale, the company has mentioned the second, pending patent in many public releases, including the prospectus for last summer's successful stock offering. Here is an excerpt:

<< The Company's pending patent application
relating to Vasomax covers both methods of use and formulations of the active ingredient in Vasomax.>>

The entire document can be accessed on Edgar.